Neuroleptic malignant syndrome

Common Name(s)

Neuroleptic malignant syndrome

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Neuroleptic malignant syndrome" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Neuroleptic malignant syndrome" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Neuroleptic malignant syndrome" returned 150 free, full-text research articles on human participants. First 3 results:

Neuroleptic malignant syndrome with thyroid disorder: An unusual case report.
 

Author(s): Fan Zhang, Parisa Kanzali, Vadim Rubin, Chris Paras, Joel Goldman

Journal: Medicine (Baltimore). 2017 Sep;96(39):e8191.

 

Neuroleptic malignant syndrome (NMS) is a life threatening neurologic emergency associated with neuroleptic or antipsychotic agent use. NMS is rarely related to thyroid disease.

Last Updated: 31 Dec 1969

Go To URL
"Brief" Aripiprazole-induced Neuroleptic Malignant Syndrome with Symptoms that Only Lasted a Few Hours.
 

Author(s): Naoto Mizumura, Masato Uematsu, Aya Ito, Satoshi Okumura, Hiromitsu Maehira, Masao Ogawa, Masayasu Kawasaki

Journal: Intern. Med.. 2017 Nov;56(22):3089-3092.

 

Neuroleptic malignant syndrome (NMS) with characteristic symptoms is a potentially lethal reaction to antipsychotic drugs. Atypical NMS usually lacks major symptoms and frequently occurs after treatment using atypical antipsychotics, such as aripiprazole. A 64-year-old man developed ...

Last Updated: 31 Dec 1969

Go To URL
Reversible splenial lesion syndrome with a hyperosmolar hyperglycemic state and neuroleptic malignant syndrome caused by olanzapine.
 

Author(s): Kenta Kaino, Ryo Kumagai, Shoko Furukawa, Momoko Isono, Aiko Muramatsu, Masanao Fujii, Yumiko Muta, Tomoyuki Asada, Kazuya Fujihara, Hiroaki Yagyu

Journal: J Diabetes Investig. 2017 May;8(3):392-394.

 

A 27-year-old woman with panic disorder taking 20 mg olanzapine daily for 4 months was admitted to Mito Kyodo General Hospital, Mito, Ibaraki, Japan, because of disturbed consciousness with fever, hyperglycemia, hyperosmolarity and elevated creatine phosphokinase. She was diagnosed ...

Last Updated: 31 Dec 1969

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Neuroleptic malignant syndrome" returned 24 free, full-text review articles on human participants. First 3 results:

A Case Report of Catatonia and Neuroleptic Malignant Syndrome With Multiple Treatment Modalities: Short Communication and Literature Review.
 

Author(s): Yu-Jie Chiou, Yu Lee, Chin-Chuen Lin, Tiao-Lai Huang

Journal: Medicine (Baltimore). 2015 Oct;94(43):e1752.

 

We describe a case with complicated clinical presentations who was difficult to treat. We described the possible etiologies and differential diagnosis of neuroleptic malignant syndrome (NMS), catatonia, and infection, in details. This patient was also referred to neuro-intensive care ...

Last Updated: 31 Dec 1969

Go To URL
Neuroleptic Malignant Syndrome: A Review from a Clinically Oriented Perspective.
 

Author(s): Lurdes Tse, Alasdair M Barr, Vanessa Scarapicchia, Fidel Vila-Rodriguez

Journal: Curr Neuropharmacol. 2015 ;13(3):395-406.

 

Neuroleptic malignant syndrome (NMS) is a rare but potentially life-threatening side-effect that can occur in response to treatment with antipsychotic drugs. Symptoms commonly include hyperpyrexia, muscle rigidity, autonomic dysfunction and altered mental status. In the current review ...

Last Updated: 31 Dec 1969

Go To URL
Neuroleptic malignant syndrome with slight elevation of creatine kinase in serum: a brief review.
 

Author(s): Jordi León-Caballero, Leila Alba-Pale, Purificación Salgado-Serrano, Víctor Pérez-Solà

Journal: Actas Esp Psiquiatr. 2015 Sep;43(5):194-6.

 

Last Updated: 31 Dec 1969

Go To URL
 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov